Shanghai Huaota Biopharmaceutical Co., Ltd.

This study tested the safety and tolerability of a single dose of HB0043, a lab-made antibody that targets two inflammatory proteins (IL-17A and IL-36R), in 52 healthy adults aged 18 to 55. Participants received either the drug or a placebo, and researchers monitored for side eff…